PCN4- ECONOMIC CONSEQUENCES OF DIFFERENCES IN THE ADVERSE-EVENTS (AE) PROFILE OF CAPECITABINE vs. MAYO CLINIC (M) -REGIMEN IN PREVIOUSLY UNTREATED ADVANCED/ METASTATIC COLORECTAL CANCER.
Abstract
Authors
K Hieke C Twelves M Boyer M Findlay C Weitzel C Barker B Osterwalder C Jamieson